High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody-Mediated Rejection After Kidney Transplantation: A Cost Analysis

Autor: Tanriover, B., Wright, S.E., Foster, S.V., Roush, K.S., Castillo-Lugo, J.A., Fa, K., Levy, F.L., Mejia, A.
Zdroj: In Transplantation Proceedings 2008 40(10):3393-3396
Databáze: ScienceDirect